Coverage
-
September 30, 2021
An investor suit against biopharmaceutical company MacroGenics was dismissed on Wednesday by a Maryland federal judge who said the plaintiffs failed to show enough facts to support their claims of fraud and scienter.
1 other articles on this case.
View all »